Efficient production of cellobionic acid using whole-cell biocatalyst of genetically modified Pseudomonas taetrolens

Bioprocess Biosyst Eng. 2022 Jun;45(6):1057-1064. doi: 10.1007/s00449-022-02725-9. Epub 2022 Apr 12.

Abstract

Pseudomonas taetrolens has previously been shown to convert cellobiose to cellobionic acid (CBA), which can potentially be used in cosmetics, food, and pharmaceutical industries. The cellobiose-oxidizing activity of the P. taetrolens strain, which expressed the homologous quinoprotein glucose dehydrogenase (GDH), was increased by approximately 50.8% compared to the original strain. Whole-cell biocatalyst (WCB) of the genetically modified P. taetrolens strain [pDSK-GDH] was prepared simply by fermentation and washing processes. Reaction conditions for the proper use of WCB, such as reaction temperature, cell density to be added, and cell harvest time for preparing WCB, were investigated. The highest CBA productivity (18.2 g/L/h) was achieved when WCB prepared in the late-exponential phase of cell culture was used at 35 °C with cell density of 10 at OD600nm. Under these conditions, 200 g/L of cellobiose was all converted to CBA in 11 h, and the WCB of P. taetrolens [pDSK-GDH] maintained the maximum catalytic activity during at least six cycles without a significant decline in the productivity. Our results suggest that the manufacture of WCB based on genetically engineered P. taetrolens and its optimized use could be further developed as an economically viable option for the large-scale production of CBA.

Keywords: Cellobionic acid; Cellobiose; Pseudomonas taetrolens; Quinoprotein glucose dehydrogenase; Whole-cell biocatalyst.

MeSH terms

  • Cellobiose*
  • Disaccharides*
  • Pseudomonas / genetics
  • Pseudomonas / metabolism

Substances

  • Disaccharides
  • Cellobiose
  • cellobionic acid

Supplementary concepts

  • Pseudomonas taetrolens